|
|
|
|
Vol. 300, Issue 2, 673-680, February 2002
Autonomic Neuroscience Institute, Royal Free and University College Medical School, Royal Free Campus, Hampstead, United Kingdom (S.G.B., G.B., B.F.K.); Department of Biochemistry and Molecular Biology, University College London, London, United Kingdom (A.T.N.); and Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland (K.A.J.)
| |
Abstract |
|---|
|
|
|---|
Rat P2X1 and P2X2 subunits were coexpressed in defolliculated Xenopus oocytes and the resultant P2X receptors studied under voltage-clamp conditions. Extracellular ATP elicited biphasic inward currents, involving an initial rapidly inactivating (P2X1-like) component and a later slowly inactivating (P2X2-like) component. The maximum amplitude of P2X1-like ATP responses was increased in some cells by lowering extracellular pH (from 7.5 to 6.5), whereas P2X2-like responses and those of homomeric rP2X1 and rP2X2 receptors were not changed by this treatment. Concentration-response (C/R) curves for ATP for pH-enhanced P2X1-like responses were biphasic, and clearly distinct from monophasic ATP C/R curves for homomeric rP2X1 and rP2X2 receptors. Under acidic (pH 5.5 and 6.5) and alkaline (pH 8.5) conditions, ATP C/R curves for P2X1-like responses showed increases in agonist potency and efficacy, compared with data at pH 7.5, but the same was not true of homomeric rP2X1 and rP2X2 receptors. ATP C/R curves for P2X2-like responses overlay C/R curves for homomeric rP2X2 receptors, and determinations of agonist potency and efficacy were identical for P2X2-like and P2X2 responses at all pH levels tested. Our results show that P2X1-like responses possessed the kinetics of homomeric P2X1 receptors but an acid sensitivity different from homomeric P2X1 and P2X2 receptors. In contrast, the P2X2-like responses exactly matched the profile expected of homomeric P2X2 receptors. Thus, coexpression of P2X1 and P2X2 subunits yielded a mixed population of homomeric and heteromeric P2X receptors, with a subpopulation of novel pH-sensitive P2X receptors showing identifiably unique properties that indicated the formation of heteromeric P2X1/2 ion channels.
| |
Introduction |
|---|
|
|
|---|
ATP
acts as a fast excitatory transmitter in the central, peripheral, and
enteric nervous systems (Ralevic and Burnstock, 1998
). Here,
extracellular ATP exerts its effects through two classes of P2
receptors: the P2X and P2Y families (Burnstock and King, 1996
). Seven
subunits of the P2X receptor class (P2X1-7) have
been cloned thus far. P2X subunits have two membrane-spanning domains
connected by a large cysteine-rich extracellular loop, with three, or
possibly four, subunits assembling to form ligand-gated cation channels
selective for ATP (Brake et al., 1994
; Valera et al., 1994
; Bo et al.,
1995
; Chen et al., 1995
; Collo et al., 1996
; Surprenant et al.,
1996
; Kim et al., 1997
; Nicke et al., 1998
).
Transcripts for all but the P2X7 subunit have
been found in sensory, sympathetic, and auditory nerves (Collo et al.,
1996
; Xiang et al., 1999
). It has been suggested that this overlap
allows for the coassembly of P2X receptor subunits into heteromeric
complexes with distinct phenotypic properties. Indeed, coexpression of
P2X2 and P2X3 subunits
results in the formation of a heteromer that shows pharmacological
properties distinct from homomeric P2X2 or
P2X3 receptors (Lewis et al., 1995
; Liu et al.,
2001
). The formation of heteromeric P2X2/3
receptors has, in part, helped explain the pharmacological properties
of some P2X receptors in sensory and sympathetic nerves (Khakh et al.,
1995
; Lewis et al., 1995
; Radford et al., 1997
; Zhong et al., 2000
).
Similar work has been conducted with P2X4 and
P2X6 subunits, the transcripts of which show an
overlapping expression in regions of adult rat brain, with the
translated proteins generating a heteromeric P2X ion channel (Lê
et al., 1998
). P2X1 and
P2X5 transcripts show an overlapping expression
in the ventral horn of the spinal cord (Collo et al., 1996
) and the
coexpression of these subunits results in yet another P2X receptor
phenotype (Torres et al., 1998
). P2X2 and
P2X6 transcripts coexist in respiratory centers
in the rat brainstem and these two subunits form heteromeric
P2X2/6 receptors with distinct properties (King
et al., 2000
).
Biochemical evidence, from coimmunoprecipitation experiments, has
supported the possible association of P2X1 and
P2X2 subunits and formation of a heteromeric
receptor (Torres et al., 1999
). However, supporting evidence for in
vivo formation of P2X1/2 heteromers rests solely
with the colocalization of P2X1 and
P2X2 transcripts and their proteins. Overlapping
expression of P2X1 and P2X2
transcripts is seen in sensory and auditory nerves and in regions of
the developing rat brain (Kidd et al., 1995
; Xiang et al., 1998
, 1999
).
Furthermore, positive immunoreactivity is seen for
P2X1 and P2X2 subunits in the dorsal horn of the spinal cord and selected regions of the adult
rat brain (Kanjhan et al., 1996
; Vulchanova et al., 1996
; Loesch and
Burnstock, 1998
).
Where homomeric and heteromeric P2X receptors have been studied and
compared, it has been difficult to clearly distinguish one receptor
subtype from another solely on the basis of their agonist profiles.
However, another way to differentiate P2X subtypes is to monitor their
reaction to changes in extracellular pH. Past studies have revealed
homomeric P2X2 receptors show an increase in
agonist potency, without changing the maximum response, when the
bathing solution is made more acidic (pH <7.5) and a decrease in
agonist potency, without changing the maximum response, under more
alkaline conditions (pH > 7.5) (King et al., 1996c
, 1997
; Stoop
et al., 1997
). Other studies have revealed homomeric
P2X1 receptors show a different pattern of pH
sensitivity: a decrease in agonist potency, without change in the
maximum response, under acidic conditions and no effect on agonist
potency and efficacy under alkaline conditions (Stoop et al., 1997
;
Wildman et al., 1999
). Where either P2X1 or
P2X2 subunits have been coexpressed with other
P2X subunits (e.g., P2X3,
P2X5, or P2X6), the
resultant heteromeric P2X receptors show a pH sensitivity that is
different from the phenotype expected of homomeric
P2X1 and P2X2 receptors (King et al., 2000
; Surprenant et al., 2000
; Liu et al., 2001
).
In the present study, the possibility of heteromeric assemblies of P2X1 and P2X2 subunits was examined by comparing, at different extracellular pH levels, the pharmacological and kinetic profiles of recombinant P2X receptors formed by coexpression of these two P2X subunits in defolliculated Xenopus oocytes. The results indicate the presence of a novel pH-sensitive P2X receptor phenotype and highlight the increased complexity in ATP-mediated excitatory transmission through heteropolymerization of P2X subunits.
| |
Materials and Methods |
|---|
|
|
|---|
Preparation and Injection of Oocytes with Capped RNA (cRNA).
Xenopus laevis were anesthetized with Tricaine
(3-aminobenzoic acid ethyl ester; 0.2%, w/v; Sigma Chemical, Poole,
Dorset, UK) and killed by decapitation. Mature oocytes (stages V
and VI) were harvested and prepared for injection as described in
detail previously (King et al., 1997
). Defolliculated oocytes do not possess native P1 or P2 receptors that might otherwise complicate the
analysis of agonist activity (King et al., 1996a
,b
). Defolliculated oocytes were injected cytosolically with a mixture of cRNAs. This cRNA
mixture consisted of 20 nl of cRNA encoding rat
P2X1 (1 µg/µl; Valera et al., 1994
) and 20 nl
of cRNA encoding rat P2X2 (0.002 µg/µl; Brake
et al., 1994
). Some batches of oocytes were injected with 40 nl of cRNA
for either rat P2X1 or rat
P2X2 alone. Injected oocytes were incubated at
18°C in Barth's solution, pH 7.5, containing 110 mM NaCl, 1 mM KCl,
2.4 mM NaHCO3, 7.5 mM Tris-HCl, 0.33 mM Ca(NO3)2, 0.41 mM
CaCl2, 0.82 mM MgSO4,
supplemented with 50 µg l
1 gentamycin sulfate
for 24 h and then stored at 4°C for up to 10 days.
Electrophysiology.
Membrane currents were recorded under
voltage-clamp conditions by using a twin-electrode amplifier (Axoclamp
2B; Axon Instruments, Union City, CA). Intracellular microelectrodes
were filled with 3 M KCl and showed 1 to 2 M
resistance. Oocytes
were placed in a Perspex recording chamber and perfused at a constant
rate of 5 ml·min
1 with Ringer's solution
containing 110 mM NaCl, 2.5 mM KCl, 5 mM HEPES, 1.8 mM
BaCl2, adjusted to pH 7.5. The pH level of all drugs solutions stated in the text was adjusted by adding either 1 N
HCl or 1 N NaOH. Solutions were delivered by a gravity flow system from
separate reservoirs placed above the recording chamber. All drugs were
prepared in nominally Ca2+-free Ringer's
solution at the concentrations stated in the text. Agonists were
perfused for 30 s or until the evoked current reached a maximum.
Applications of agonists were separated by intervals of 20 min. All
recordings were made at room temperature (18°C) and at a holding
potential of between
60 and
90 mV. Electrophysiological data were
recorded using the software package Acqknowledge III (Biopac Systems;
Goleta, CA).
Data Analysis.
EC50 values for
agonists were taken from Hill plots by using the transformation log
(I/Imax
I),
where I is the current evoked by each concentration of
agonist. Hill coefficients were also taken from the slope of these
plots. Concentration/response (C/R) curves were fitted by nonlinear
regression analysis by using commercial software (Prism version 2.0;
GraphPad Software, San Diego, CA). Data are presented as mean ± S.E.M. of four or more determinations. Significant differences were
determined by either unpaired Student's t test or one-way
analysis of variance followed by Dunnett's test, by using
commercially available software (Instat version 2.05a; GraphPad Software).
Chemicals.
All common salts were AnalaR grade (Aldrich
Chemical, Gillingham, UK). ATP disodium salt was purchased from Roche
Molecular Biochemicals (Mannheim, Germany) and Sigma/RBI
(Natick, MA).
P1,P6-Diadenosine
hexaphosphate (Ap6A, ammonium salt),
,
-methylene ATP (
,
-meATP, lithium salt) were purchased from
Sigma Chemical. Agonist solutions were prepared daily, made up in
extracellular bathing medium, and the pH adjusted to the desired level.
| |
Results |
|---|
|
|
|---|
Use of Acidic Conditions to Distinguish Types of P2X
Receptors.
The coexpression of two P2X subunits, individually
capable of forming homomeric P2X receptors (e.g.,
P2X2 and P2X3), has been shown to generate a mixed population of homomeric and heteromeric assemblies (Liu et al., 2001
). This finding also appeared to be true
for P2X1/P2X2
cRNA-coinjected oocytes. Here, ATP (100 µM) evoked biphasic inward
currents that comprised an initial rapidly inactivating
(P2X1-like) component followed by a second slowly inactivating (P2X2-like) component (Fig.
1). Thus, it was necessary to find a way
to separate the agonist responses of homomeric
rP2X1 and rP2X2 receptors
from those mediated by putative heteromeric P2X1/2 receptors.
|
Potency of Agonists Mediating pH-Sensitive Inward
(P2X1-Like) Currents.
Recombinant P2X receptors in
coinjected oocytes reacted to very low concentrations of ATP, with a
threshold below 10 nM, and were activated maximally at high ATP
concentrations (100-300 µM). The amplitude of these rapidly
inactivating P2X1-like responses grew
incrementally over this extended concentration range (10 nM-300 µM)
(Fig. 2A), whereas the slower
P2X2-like responses were evident only over a
limited concentration range (approximately 3-300 µM). The C/R curve
for ATP activated P2X1-like responses is shown in
Fig. 3A. The apparent
EC50 value (and Hill coefficient) was 0.56 ± 0.09 µM (nH = 0.37)
(n = 9), but the C/R curve was shallow and appeared to
be biphasic. Resolving for each phase, mean EC50
values were 54 nM (nH = 1.05) and 3.28 µM (nH = 0.82). This first
EC50 value matches a determination for ATP
potency at homomeric hP2X1 receptors (mean
EC50 of 56 nM; Bianchi et al., 1999
), but is
statistically lower (p < 0.05) than our present determination for homomeric rP2X1 receptors (mean
EC50 of 98 nM; nH = 0.80) (Fig. 3B). The second
EC50 value is unrelated to any determination for
ATP potency at homomeric P2X1 receptors.
|
|
,
-meATP also evoked rapidly
inactivating P2X1-like responses in
P2X1/P2X2 cRNA-coinjected
oocytes (Fig. 2B). Ap6A is inactive at homomeric
rP2X2 receptors (Jacobson et al., 2000
,
-meATP is a weak agonist at homomeric P2X2 receptors (Jiang et al., 2001
,
-meATP of 0.43 ± 0.05 µM
(nH = 0.89) (n = 8).
The C/R curve for Ap6A appeared to be biphasic,
with mean EC50 values of 49 nM
(nH = 1.37) and 2.02 µM
(nH = 1.25). However, we were unable
to dissect the C/R curve for
,
-meATP into two phases even though
the C/R curve was shallow. Agonist potency data are summarized in Table 1.
|
Effects of Extracellular pH on Agonist Efficacy at
P2X1-Like Responses.
The C/R relationship for rapidly
inactivating P2X1-like ATP responses was
reexamined at four different levels of pHe (Fig. 4, A-D). At the four levels tested (pH
8.5, 7.5, 6.5, and 5.5), the resultant C/R curves extended over 5 log10 units of agonist concentration (1 nM-100
µM) and the slopes of these curves were shallow
(nH
0.5). It was difficult to
dissect some ATP C/R curves into first and second phases, particularly
at pH 5.5, where agonist sensitivity was heightened. However, it was
clear that the amplitude of P2X1-like responses
was consistently greater under acidic conditions at all ATP
concentrations tested (especially at pH 6.5 and 5.5) (Fig. 4, C and D).
Compared with control data at pH 7.5, the relative amplitude of the
maximum response (Imax) was 134 ± 8% (at pH 6.5; n = 6) and 284 ± 18% (at pH
5.5; n = 4). Thus, one effect of acidic pHe was an increase in agonist efficacy.
|
Effects of Extracellular pH on Agonist Potency at P2X1-Like Responses. The effects of extracellular pH on agonist potency were assessed in one of two ways. Where there was no clear boundary between two phases of the C/R curve (particularly at pH 6.5 and 5.5), agonist potency was assessed as the EC50 value over the full concentration range (1 nM-100 µM) (Fig. 4). Where possible, C/R curves were analyzed over first and second phases of the curve and changes in EC50 values noted. This was only possible for C/R curves defined at pH 7.5 and pH 8.5 (Fig. 4).
Where C/R curves were analyzed over the full concentration range, apparent EC50 values were as follows for P2X1-like responses: pH 8.5, 0.39 ± 0.13 µM (n = 5); pH 7.5, 0.55 ± 0.09 µM (n = 9); pH 6.5, 0.08 ± 0.02 µM (n = 6); and pH 5.5, 0.12 ± 0.05 µM (n = 4). Thus, ATP potency was not significantly different at pH 8.5 and 7.5, yet was enhanced by 5- to 7-fold at pH 6.5 and 5.5. These results contrast with data for homomeric rP2X1 receptors where it is known that ATP potency is reduced under acidic conditions (Stoop et al., 1997
|
Potency of Agonists Mediating Slow Inward (P2X2-Like)
Currents.
Slowly inactivating P2X2-like
responses were evoked at ATP concentrations in excess of 3 µM and
maximal at high concentrations (300 µM) (Fig. 2A). It was not
possible to determine the threshold concentration required to elicit
these slow responses, because the initial
P2X1-like responses showed deactivating tail
currents that obscured the smallest of P2X2-like
responses. The C/R curve for ATP-mediated
P2X2-like responses is shown in Fig.
5. At pH 7.5, the apparent
EC50 value (and Hill coefficient) was 7.7 ± 0.6 µM (nH = 1.00) for the
P2X2-like response, which was not significantly different from the determination for homomeric
rP2X2 receptors (5.6 ± 0.5 µM;
nH = 1.21) (Fig. 5). At pH 6.5, the
EC50 value for the
P2X2-like response was 0.71 ± 0.06 µM
(nH = 1.95), similar to the
determination for homomeric rP2X2 receptors
(1.09 ± 0.12 µM; nH = 1.81)
(Fig. 5). The ATP C/R curves for P2X2-like
responses and responses by homomeric rP2X2
receptors appeared to be monophasic at the pH levels tested. Also, the
maximum amplitude for P2X2-like responses, as for
homomeric rP2X2 receptors (King et al., 1996c
), was not significantly different at the pH levels tested (Fig. 5B).
Furthermore, Ap6A and
,
-meATP (both 30 µM) were ineffective at eliciting P2X2-like
responses (Fig. 2B) or activating homomeric rP2X2
receptors (Jacobson et al., 2000
).
|
| |
Discussion |
|---|
|
|
|---|
In the present study, heterologous coexpression of
P2X1 and P2X2 subunits in
defolliculated Xenopus oocytes resulted in the formation of
a complex population of P2X receptors. Activation of these P2X
receptors with extracellular ATP resulted in biphasic inwards currents
that involved rapidly and slowly inactivating components and, at first
glance, these results could be explained by the successive activation
of homomeric P2X1 and P2X2
receptors. This conclusion has been already stated in a preliminary
report on the coexpression of P2X1 and
P2X2 subunits (Lewis et al., 1995
). In the
intervening time, however, much more has been learned about the
operational profiles of homomeric rP2X1 and
rP2X2 receptors, not least, the influence of
extracellular pH on agonist activity (King et al., 1996c
, 1997
, 2000
;
Stoop et al., 1997
; Stoop and Quayle, 1998
; Wildman et al., 1997
, 1999
;
Ding and Sachs, 1999
). Also, further recent biochemical evidence has
suggested that P2X1 and
P2X2 subunits can heteropolymerize (Torres et
al., 1999
).
By lowering extracellular pH (from pH 7.5 to 6.5), we noted that a
relatively small sample (14 of 87 cells) of
P2X1/P2X2 cRNA-coinjected oocytes responded to ATP with rapidly inactivating inward currents (P2X1-like responses) that were potentiated under
acidic conditions. This behavior was atypical of fast inward currents
carried by homomeric rP2X1 receptors, which are
inhibited under acidic conditions by a mechanism that decreases ATP
potency (Stoop et al., 1997
; Wildman et al., 1999
). On the other hand,
P2X1-like responses in a sample of 73 of 87 cells
were decreased under acidic conditions and, here, we have assumed that
homomeric rP2X1 receptors were in abundance.
Thus, we believe the cellular conditions in oocytes may favor the
assembly of homomeric P2X1 receptors over
heteromeric P2X1/2 receptors, although these
heteromeric assemblies appear to be abundant in approximately one in
six cells. In this limited population of cells, the outcome of lowering
extracellular pH seemed more in keeping with homomeric
P2X2 receptors, at which the amplitude of
submaximal ATP responses is enhanced under acidic conditions by a
mechanism increasing ATP potency (King et al., 1996c
, 1997
, 2000
; Stoop
et al., 1997
; Ding and Sachs, 1999
). Thus,
P2X1-like responses possessed the kinetics of
homomeric P2X1 receptors and, to an extent, the
acid sensitivity of homomeric P2X2 receptors. It
is therefore possible that a significant part of
P2X1-like responses was mediated by heteromeric
P2X1/2 receptors sharing some of the properties
of their constituent P2X subunits.
Alternatively, it could be argued that, in those cells showing a
potentiation of P2X1-like responses under acidic
conditions, this effect was no more than the relaxation of receptor
desensitization for a significant proportion of the available homomeric
P2X1 receptor population. However, several lines
of evidence disprove this argument. First, the amplitude of
P2X1-like responses under control conditions was
constant for successive agonist applications, consistently potentiated
under acidic conditions, and returned to control values when pH levels
were restored (Fig. 6). Second, the
potentiation of P2X1-like responses under acidic
conditions was due to an increase in ATP potency, an effect unrelated
to the number of P2X receptors available for activation. Third,
P2X1-like responses could be evoked by very low
agonist concentrations, not only ATP but also Ap6A and
,
-meATP, in contrast to parallel
experiments where homomeric P2X1 receptors were
studied separately. None of these observations are consistent with the
behavior of desensitized homomeric P2X1
receptors.
|
Only one in every six
P2X1/P2X2 cRNA-coinjected
oocytes showed pH-potentiated P2X1-like responses
and, accordingly, it was difficult to carry out extensive
pharmacological investigations. We altered the concentrations of
injected cRNAs in an attempt to increase the expression of heteromeric
P2X assemblies, as carried out in our experiments on heteromeric
P2X2/3 receptors (Liu et al., 2001
), but this
procedure only resulted in cells with P2X receptors showing the
expected properties of homomeric P2X1 and P2X2 receptors (data not shown). This outcome may
explain, in part, why a previous attempt using human embryonic kidney
293 cells to coexpress P2X1 and
P2X2 subunits failed to reveal the presence of
heteromeric P2X1/2 assemblies (Lewis et al.,
1995
). Also, these investigators were faced with the problem of finding a way of pharmacologically dissecting heteromeric and homomeric P2X
receptors present when, at that time, the discriminating effects of
extracellular pH were unknown.
Where P2X1/P2X2
cRNA-coinjected cells were studied, agonist activation of the mixed P2X
receptor population resulted in complex C/R curves for pH-potentiated
P2X1-like responses. C/R curves extended over a
large concentration range and, at pH 7.5, were clearly biphasic for ATP
and Ap6A. It seems likely that biphasic C/R
curves resulted from the separate activation of different populations
of P2X assemblies capable of generating rapidly inactivating P2X1-like responses. It is less likely that the
second phase of complex C/R curves was caused by a simultaneous
activation of homomeric P2X1 and
P2X2 ion channels and the summation of inward currents, particularly in the case of Ap6A or
,
-meATP, which are inert at rP2X2 receptors
(Table 1). Also, elevation of the second phase of the ATP C/R curve at
pH 8.5 (Fig. 4B) was inconsistent with the actions of alkaline bathing
solutions at homomeric rP2X2 receptors (King et
al., 1997
). Furthermore, the elevation of ATP C/R curves for
P2X1-like responses under acidic conditions (Fig. 4, C and D) was equally incompatible with the involvement of homomeric rP2X2 receptors (King et al., 1997
).
EC50 values for ATP and
Ap6A fell in the region of 50 nM for the first
phase of C/R curves for P2X1-like responses,
significantly different (p < 0.05) from agonist
EC50 values at homomeric
rP2X1 receptors (Fig. 3; Table 1). It has been
reported that rapidly inactivating inward currents elicited by
heteromeric P2X1/5 receptors are also evoked by
very low ATP concentrations (mean EC50 of 55 nM)
(Surprenant et al., 2000
). Thus, a trend is emerging that P2X
heteromers comprising P2X1 subunits are extremely
sensitive to ATP and, conceivably, this represents a useful adaptation
to enhance purinergic signaling at sites where homomeric
P2X1 receptors are also used.
EC50 values for the second phase were in the low micromolar (~2-3 µM) concentration range and these values were unrelated to EC50 values for homomeric
P2X1 or P2X2 receptors (Table 1). Where EC50 values were determined over
the full range of data points for each C/R curve, the agonist potency
order was
,
-meATP > ATP > Ap6A,
which, again, was unrelated to data for homomeric
rP2X1 receptors (ATP > Ap6A >
,
-meATP) and homomeric rP2X2 receptors (ATP active,
,
-meATP, a
weak agonist, and Ap6A inactive) (Table 1).
A thorough study of ATP potency and efficacy at different extracellular
pH levels provided further evidence that
P2X1-like responses were mediated by novel
pH-sensitive heteromeric P2X receptors. Here, we found that lowering
pHe caused an increase the maximum ATP response
and displaced the C/R curve in a leftwards manner. In contrast, acidic
conditions decrease ATP potency without altering the maximum response
at homomeric rP2X1 receptors (Stoop et al., 1997
;
Wildman et al., 1999
) (Table 2), or increase ATP potency without
altering the maximum response at homomeric P2X2 receptors (King et al., 1996c
, 1997
; Stoop et al., 1997
) (Fig. 5). In
the present study, we observed that raising pHe
increased the maximum ATP response without altering agonist potency for P2X1-like currents, whereas, in contrast,
alkaline conditions have no effect on ATP responses at homomeric
P2X1 receptors (Wildman et al., 1999
), or
decrease ATP potency without changing the maximum response at homomeric
P2X2 receptor (King et al., 1996c
, 1997
).
It seemed unlikely that P2X1-like responses were
mediated by homomeric P2X2 receptors, for a
number of reasons. The P2X1-like responses were
rapidly inactivating, evoked by Ap6A and
,
-meATP, and their maximal amplitude potentiated by both acidic
and alkaline conditions. None of these features match the profile of
homomeric rP2X2 receptors (King et al., 1997
;
Jacobson et al., 2000
). Instead, there appeared to be a major role for
homomeric rP2X2 receptors in the later
P2X2-like responses that showed the appropriate
sensitivity to ATP at all pH levels tested.
To the best of our knowledge, there are no reports of native P2X
receptors in neural systems that are similar to the findings in this
study, although our attention was drawn to a report on the guinea pig
vas deferens where P2X1-like responses are
potentiated under acidic conditions (Nakanishi et al., 1999
). However,
the molecular characterization of the guinea pig
P2X1 receptor is required before further
conclusions can be drawn. The recent report of phenotypically altered
rat P2X1 receptors generated by alternative splicing (Greco et al., 2001
) further complicates the comparison of
native and recombinant P2X receptor responses. We are left with the
conclusion that heteromeric assemblies of rP2X1
and rP2X2 subunits would best explain the unique
pH sensitivity and unusual pharmacological activity of agonists at
P2X1-like responses. P2X receptors are now viewed
as either trimeric or tetrameric assemblies (Kim et al., 1997
; Nicke et
al., 1998
) and, hence, expression of heteromeric
P2X1/2 receptors could involve from one to three P2X1 subunits. Perhaps such differences in
subunit composition of heteromeric P2X1/2
receptors can help explain the complex C/R curves observed in our
study, but that is a matter of conjecture. We envision naturally
occurring P2X1/2 receptors to be activated by
very low concentrations of released ATP and Ap6A,
and that purinergic transmission would be facilitated under the acidic environment associated with exocytosis of neurotransmitters or with
tissue inflammation (King et al., 1997
).
| |
Acknowledgments |
|---|
We thank Dr. Gary Buell (Ares Serono, Geneva, Switzerland) and Professor David Julius (University of California, San Francisco, CA) for the rP2X1 and rP2X2 plasmids, respectively.
| |
Footnotes |
|---|
Accepted for publication November 12, 2001.
Received for publication September 12, 2001.
This work was supported by grants from the Biotechnology and Biological Sciences Research Council (UK) and British Heart Foundation (UK), as well as by funding from Gilead Sciences (Foster City, CA) and Roche Bioscience (Palo Alto, CA). S.G.B. was supported by Gilead Sciences; this work appears as part of S.G.B.'s Ph.D. thesis, entitled: Pharmacological Agents That Distinguish between P2X Receptor Subtypes, University of London, Senate House, London.
Address correspondence to: Brian F. King, Ph.D., Autonomic Neuroscience Institute, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill St., Hampstead, London NW3 2PF, UK. E-mail: b.king{at}ucl.ac.uk
| |
Abbreviations |
|---|
cRNA, capped RNA;
C/R, concentration-response;
Ap6A, P1,P6-diadenosine
hexaphosphate ammonium salt;
,
-meATP,
,
-methylene ATP
lithium salt;
pHe, extracellular pH.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. Casas-Pruneda, J. P. Reyes, G. Pérez-Flores, P. Pérez-Cornejo, and J. Arreola Functional interactions between P2X4 and P2X7 receptors from mouse salivary epithelia J. Physiol., June 15, 2009; 587(12): 2887 - 2901. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Dubyak Go It Alone No More P2X7 Joins the Society of Heteromeric ATP-Gated Receptor Channels Mol. Pharmacol., December 1, 2007; 72(6): 1402 - 1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cavaliere, S. Amadio, K. Dinkel, K. G. Reymann, and C. Volonte P2 Receptor Antagonist Trinitrophenyl-Adenosine-Triphosphate Protects Hippocampus from Oxygen and Glucose Deprivation Cell Death J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 70 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ma, A. Korngreen, S. Weil, E. B.-T. Cohen, A. Priel, L. Kuzin, and S. D. Silberberg Pore properties and pharmacological features of the P2X receptor channel in airway ciliated cells J. Physiol., March 15, 2006; 571(3): 503 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kennedy P2X Receptors: Targets for Novel Analgesics? Neuroscientist, August 1, 2005; 11(4): 345 - 356. [Abstract] [PDF] |
||||
![]() |
L. Papp, T. Balazsa, A. Kofalvi, F. Erdelyi, G. Szabo, E. S. Vizi, and B. Sperlagh P2X Receptor Activation Elicits Transporter-Mediated Noradrenaline Release from Rat Hippocampal Slices J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 973 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Calvert and R. J. Evans Heterogeneity of P2X Receptors in Sympathetic Neurons: Contribution of Neuronal P2X1 Receptors Revealed Using Knockout Mice Mol. Pharmacol., January 1, 2004; 65(1): 139 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Spyer, N. Dale, and A. V. Gourine Festschrift for R. G. O'Regan - Sensing and adaptation to alterations in respiratory gases: oxygen and carbon dioxide: ATP is a key mediator of central and peripheral chemosensory transduction Exp Physiol, January 1, 2004; 89(1): 53 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V Gourine, L. Atkinson, J. Deuchars, and K M. Spyer Purinergic Signalling in the Medullary Mechanisms of Respiratory Control in the Rat: Respiratory Neurones Express the P2X2 Receptor Subunit J. Physiol., October 1, 2003; 552(1): 197 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsuzuki, A. Ase, P. Seguela, T. Nakatsuka, C.-Y. Wang, J.-X. She, and J. G. Gu TNP-ATP-Resistant P2X Ionic Current on the Central Terminals and Somata of Rat Primary Sensory Neurons J Neurophysiol, June 1, 2003; 89(6): 3235 - 3242. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakatsuka, K. Tsuzuki, J. X. Ling, H. Sonobe, and J. G. Gu Distinct Roles of P2X Receptors in Modulating Glutamate Release at Different Primary Sensory Synapses in Rat Spinal Cord J Neurophysiol, June 1, 2003; 89(6): 3243 - 3252. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nicke, J. Rettinger, and G. Schmalzing Monomeric and Dimeric Byproducts are the Principal Functional Elements of Higher Order P2X1 Concatamers Mol. Pharmacol., January 1, 2003; 63(1): 243 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Wildman, S. G. Brown, M. Rahman, C. A. Noel, L. Churchill, G. Burnstock, R. J. Unwin, and B. F. King Sensitization by Extracellular Ca2+ of Rat P2X5 Receptor and Its Pharmacological Properties Compared with Rat P2X1. Mol. Pharmacol., October 1, 2002; 62(4): 957 - 966. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||